Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2014; 20(9): 2143-2158
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2143
Table 3 Published randomized controlled trials of pentoxifylline vs placebo for severe alcoholic hepatitis n (%)
Ref.nDuration of treatment with pentoxifylline 400 mg PO tidMortality in placeboMortality in pentoxifyllineRelative risk or hazard ratio95%CIComments
Akriviadis et al[110], 200010128 d24/52 (46)12/49 (24)RR = 0.590.35-0.97Positive study (P = 0.037)
Fernández-Rodríguez et al[112], 20082428 dNot reported1Not reported1HR = 1.460.5-4.28Negative study (P = 0.48)
Tyagi et al[107], 20116126 mo2/31 (6)1/30 (3)Not reportedNot reportedNegative study2 (P = 0.15)
Sidhu et al[109], 20125028 d10/25 (40)5/25 (20)RR = 0.50.19-1.25Negative study (P = 0.216)